Journal of Applied MicrobiologyGeneticsPeer-reviewed journal article
In silico design and validation of commercial kit GPSTM CoVID-19 dtec-RT-qPCR Test under criteria of UNE/EN ISO 17025:2005 and ISO/IEC 15189:2012
Antonio Martı́nez-MurciaiD, Gema Bru, Aaron Navarro, Patricia Ros-TárragaiD, Adrián García-Sirera, L. PéreziD
Abstract
BackgroundThe Corona Virus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has become a serious infectious disease affecting human health worldwide and rapidly declared a pandemic by WHO. Early, several RT-qPCR were designed by using only the first SARS-CoV-2 genome sequence. ObjectivesA few days later, when additional SARS-CoV-2 genome were retrieved, the kit GPS CoVID-19 dtec-RT-qPCR Test was designed to provide a highly specific detection method and commercially available worldwide. The kit was validated following criteria recommended by the UNE/EN ISO 17025:2005 and ISO/IEC 15189:2012. MethodsThe present study approached the in silico specificity of the GPS CoVID-19 dtec-RT-qPCR Test and RT-qPCR designs currently published. The empirical validation parameters specificity (inclusivity/exclusivity), quantitative phase analysis (10-106 copies), reliability (repeatability/reproducibility) and sensitivity (detection/quantification limits) were evaluated for a minimum of 10-15 assays. Diagnostic validation was achieved by two independent reference laboratories, the Instituto de Salud Carlos III (ISCIII), (Madrid, Spain) and the Public Health England (PHE; Colindale, London, UK). ResultsThe GPS RT-qPCR primers and probe showed the highest number of mismatches with the closet related non-SARS-CoV-2 coronavirus, including some indels. The kits passed all parameters of validation with strict acceptance criteria. Results from reference laboratories 100% correlated with these obtained by suing reference methods and received an evaluation with 100% of diagnostic sensitivity and specificity. ConclusionsThe GPS CoVID-19 dtec-RT-qPCR Test, available with full analytical and diagnostic validation, represents a case of efficient transfer of technology being successfully used since the pandemic was declared. The analysis suggested the GPS CoVID-19 dtec-RT-qPCR Test is the more exclusive by far.
- Citations
- 6
- FWCI
- 0.20
- Field percentile
- top 33%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Comparison of commercial RT-PCR diagnostic kits for COVID-19
P. B. van Kasteren, B. van der Veer, … A. Meijer·Journal of Clinical VirologyPeer-reviewed·Jul 1, 2020
- Robust and sensitive detection of SARS-CoV-2 using PCR based methods
- Design of a Novel Multiplex Real Time RT-PCR Assay for SARS-CoV-2 Detection
W. Zhen, G. J. Berry·bioRxiv·Jun 4, 2020
- A Rapid COVID-19 RT-PCR Detection Assay for Low Resource Settings
Arunkumar Arumugam, Matthew L. Faron, … Season Wong·DiagnosticsPeer-reviewed·Sep 24, 2020
- Comparison of three TaqMan Real-Time Reverse Transcription-PCR assays in detecting SARS-CoV-2
Y. Xiao, Z. Li, … J. Li·Journal of Virological MethodsPeer-reviewed·Feb 1, 2021
- Analytical Validation of a COVID-19 qRT-PCR Detection Assay Using a 384-well Format and Three Extraction Methods
A. C. Nelson, B. Auch, … S. Yohe·bioRxiv·Apr 2, 2020